Promoter methylation of BRMS1 correlates with smoking history and poor survival in non-small cell lung cancer patients

These results provide clinical evidence to support the notion that BRMS1 is a NSCLC metastasis suppressor gene. Measuring methylation status of BRMS1 promotor is a useful marker for identifying NSCLC patients with worse disease-free survival.